VivaVision Biotech reveals promising phase 2 trial results for VVN461, a new treatment for Non-Infectious Anterior Uveitis, ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA ...

Medit, a global leader in digital dentistry solutions, and Graphy, a leading innovator in 3D printing dental materials, have ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

If your veterinarian confirms that your cat’s eyes are inflamed, they may recommend eye drops. Let’s take a closer look at ...

Cancer treatments can instigate ocular surface disease and other deleterious ocular side effects that optometrists can oversee and manage.

The prognostic score was developed based on the ACTUAL (Endovascular Treatment for Acute Anterior Circulation Ischemic Stroke) registry. The validation cohort was derived from the Captor trial.

Medicare covers cancer treatment from in-network providers. Medicare Part A covers hospitalization, and Part B covers outpatient treatment. Part C should provide similar coverage, and Part D will ...

The treatment for droopy eyelid depends on the specific cause and the severity of the ptosis. If the condition is the result of age or something you were born with, a doctor may explain that ...